Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Progressive multifocal leukoencephalopathy associated to natalizumab: the importance of magnetic resonance imaging in its early diagnosis].
Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis.
Neuropsychiatric disorders among Syrian and Iraqi refugees in Jordan: a retrospective cohort study 2012-2013.
A single dose of a neuron-binding human monoclonal antibody improves brainstem NAA concentrations, a biomarker for density of spinal cord axons, in a model of progressive multiple sclerosis.
Copper/zinc chelation by clioquinol reduces spinal cord white matter damage and behavioral deficits in a murine MOG-induced multiple sclerosis model.
B cells in Multiple Sclerosis: Good or bad guys?: An article for 28 May 2014 - World MS Day 2014.
The case for measuring anti-drug antibodies in people with multiple sclerosis.
Glutamate Release Machinery Is Altered in the Frontal Cortex of Rats with Experimental Autoimmune Encephalomyelitis.
Safety, Tolerability, and Efficacy of Oral Therapies for Relapsing-Remitting Multiple Sclerosis.
Sex and gender issues in multiple sclerosis.
Validity and reliability of the FSS in Greek MS patients.
Demyelination complicating anti-tnf therapy in inflammatory bowel disease (ibd) and other inflammatory disorders (pred4-ukcrn 11988).
Remote control-triggering of brain autoimmune disease in the gut.
Vitamin D supplementation and antibodies against the Epstein-Barr virus in multiple sclerosis patients.
Aquaporin 4 Expression and Tissue Susceptibility to Neuromyelitis Optica.
Use of a biomarker in exposure-response analysis to support dose selection for fingolimod.
Integrating multiple oestrogen receptor alpha ChIP studies: overlap with disease susceptibility regions, DNase I hypersensitivity peaks and gene expression.
Multiple Sclerosis between Genetics and Infections: Human Endogenous Retroviruses in Monocytes and Macrophages.
Two cases of lumbosacral myeloradiculitis with anti-aquaporin-4 antibody.
Reducing suffering in experimental autoimmune encephalomyelitis (EAE).
Ischemic colitis with type I interferons used in the treatment of hepatitis C and multiple sclerosis: an evaluation from the food and drug administration adverse event reporting system and review of the literature.
Perception of muscular effort in multiple sclerosis.
Large-scale production of human mesenchymal stem cells for clinical applications.
Episodic Mood Changes Preceding an Exacerbation of Multiple Sclerosis.
A randomised controlled trial of an exercise plus behaviour change intervention in people with multiple sclerosis: the step it up study protocol.
Pages
« first
‹ previous
…
501
502
503
504
505
506
507
508
509
…
next ›
last »